Alma Fulurija

1.6k total citations
38 papers, 1.2k citations indexed

About

Alma Fulurija is a scholar working on Infectious Diseases, Immunology and Surgery. According to data from OpenAlex, Alma Fulurija has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 11 papers in Immunology and 10 papers in Surgery. Recurrent topics in Alma Fulurija's work include Antifungal resistance and susceptibility (11 papers), Helicobacter pylori-related gastroenterology studies (10 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Alma Fulurija is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Helicobacter pylori-related gastroenterology studies (10 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Alma Fulurija collaborates with scholars based in Australia, Switzerland and United States. Alma Fulurija's co-authors include R. B. Ashman, J. M. Papadimitriou, J. M. Papadimitriou, Martin F. Bachmann, Robert B. Ashman, Mohammed Benghezal, Barry J. Marshall, Paul‐Henri Lambert, Claire‐Anne Siegrist and Chantal Tougne and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Alma Fulurija

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alma Fulurija Australia	19	373	325	308	237	218	38	1.2k
Marc P. Hübner Germany	25	468 1.3×	713 2.2×	214 0.7×	249 1.1×	134 0.6×	90	1.7k
Miguel A. Pineda United Kingdom	24	328 0.9×	269 0.8×	275 0.9×	353 1.5×	174 0.8×	48	1.5k
R. van Furth Netherlands	21	476 1.3×	308 0.9×	356 1.2×	227 1.0×	104 0.5×	42	1.4k
Fermı́n Lampreave Spain	27	208 0.6×	330 1.0×	134 0.4×	454 1.9×	199 0.9×	57	2.1k
Barbara Styrt United States	17	368 1.0×	234 0.7×	226 0.7×	263 1.1×	117 0.5×	39	1.2k
Christine Schütt Germany	25	1.5k 4.1×	162 0.5×	478 1.6×	381 1.6×	153 0.7×	47	2.3k
Victoria Anderson United States	25	799 2.1×	283 0.9×	319 1.0×	325 1.4×	150 0.7×	59	1.8k
Michael P. Everson United States	17	766 2.1×	148 0.5×	286 0.9×	239 1.0×	126 0.6×	32	1.5k
Lisa Ganley‐Leal United States	19	417 1.1×	124 0.4×	261 0.8×	116 0.5×	86 0.4×	41	1.1k
Sanae Sasaki Japan	19	798 2.1×	307 0.9×	699 2.3×	326 1.4×	86 0.4×	43	1.6k

Countries citing papers authored by Alma Fulurija

Since Specialization

Citations

This map shows the geographic impact of Alma Fulurija's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alma Fulurija with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alma Fulurija more than expected).

Fields of papers citing papers by Alma Fulurija

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alma Fulurija. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alma Fulurija. The network helps show where Alma Fulurija may publish in the future.

Co-authorship network of co-authors of Alma Fulurija

This figure shows the co-authorship network connecting the top 25 collaborators of Alma Fulurija. A scholar is included among the top collaborators of Alma Fulurija based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alma Fulurija. Alma Fulurija is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Osowicki, Joshua, Julie Marsh, Sam Salman, et al.. (2025). Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blind, placebo-controlled trial. The Lancet Microbe. 6(5). 101038–101038. 1 indexed citations

Fulurija, Alma, et al.. (2024). Serological Responses to Streptococcus pyogenes Vaccine Candidate Antigens Suggests That Streptococcus dysgalactiae Is the Predominant Cause of Lower Limb Cellulitis. Open Forum Infectious Diseases. 11(6). ofae272–ofae272. 1 indexed citations

Martinovich, Kelly M., Naomi M. Scott, Elke Seppanen, et al.. (2024). An infant mouse model of influenza-driven nontypeable Haemophilus influenzae colonization and acute otitis media suitable for preclinical testing of novel therapies. Infection and Immunity. 92(5). e0045323–e0045323. 1 indexed citations

Scott, Naomi M., Kelly M. Martinovich, Elke Seppanen, et al.. (2024). Nasal Delivery of Haemophilus haemolyticus Is Safe, Reduces Influenza Severity, and Prevents Development of Otitis Media in Mice. The Journal of Infectious Diseases. 230(2). 346–356. 2 indexed citations

Asturias, Edwin J., Jean‐Louis Excler, James Ackland, et al.. (2023). Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring. Clinical Infectious Diseases. 77(6). 917–924. 8 indexed citations

Debowski, Aleksandra W., Senta M. Walton, Eng Guan Chua, et al.. (2017). Helicobacter pylori gene silencing in vivo demonstrates urease is essential for chronic infection. PLoS Pathogens. 13(6). e1006464–e1006464. 60 indexed citations

Li, Hong, Tingting Liao, Aleksandra W. Debowski, et al.. (2017). The redefinition of Helicobacter pylori lipopolysaccharide O-antigen and core-oligosaccharide domains. PLoS Pathogens. 13(3). e1006280–e1006280. 39 indexed citations

Stenström, Björn, Helen M. Windsor, Alma Fulurija, et al.. (2016). Helicobacter pylori overcomes natural immunity in repeated infections. Clinical Case Reports. 4(11). 1026–1033. 3 indexed citations

Nilsson, Hans‐Olof, et al.. (2014). Phase-variable restriction/modification systems are required for Helicobacter pylori colonization. Gut Pathogens. 6(1). 35–35. 23 indexed citations

10.

Debowski, Aleksandra W., Christophe Carnoy, Phebe Verbrugghe, et al.. (2012). Correction: Xer Recombinase and Genome Integrity in Helicobacter pylori, a Pathogen without Topoisomerase IV. PLoS ONE. 7(7). 2 indexed citations

11.

Schoep, Tobias, Alma Fulurija, Wei Lü, et al.. (2010). Surface Properties of Helicobacter pylori Urease Complex Are Essential for Persistence. PLoS ONE. 5(11). e15042–e15042. 57 indexed citations

12.

Dumrese, Claudia, Lutz Slomianka, Urs Ziegler, et al.. (2009). The secreted Helicobacter cysteine‐rich protein A causes adherence of human monocytes and differentiation into a macrophage‐like phenotype. FEBS Letters. 583(10). 1637–1643. 40 indexed citations

13.

Staufenbiel, Matthias, Karl‐Heinz Wiederhold, Alain C. Tissot, et al.. (2006). O1–06–01: Immunization with Aβ1–6 coupled to the virus–like particle Qβ (CAD106) efficiently removes β–amyloid without inducing Aβ–reactive T–cells. Alzheimer s & Dementia. 2(3S_Part_1). 2 indexed citations

14.

Ambühl, Patrice M., Alain C. Tissot, Alma Fulurija, et al.. (2006). A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. Journal of Hypertension. 25(1). 63–72. 165 indexed citations

15.

Kündig, Thomas M., Gabriela Senti, Gabriel Schnetzler, et al.. (2006). Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. Journal of Allergy and Clinical Immunology. 117(6). 1470–1476. 164 indexed citations

16.

Pihlgren, Maria, Chantal Tougne, Paola Bozzotti, et al.. (2003). Unresponsiveness to Lymphoid-Mediated Signals at the Neonatal Follicular Dendritic Cell Precursor Level Contributes to Delayed Germinal Center Induction and Limitations of Neonatal Antibody Responses to T-Dependent Antigens. The Journal of Immunology. 170(6). 2824–2832. 83 indexed citations

17.

Pihlgren, Maria, Chantal Tougne, Paola Bozzotti, et al.. (2001). Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life. European Journal of Immunology. 31(3). 939–946. 64 indexed citations

18.

Ashman, R. B., Alma Fulurija, & J. M. Papadimitriou. (1998). A secondCandida albicansresistance gene (Carg2) regulates tissue damage, but not fungal clearance, in sub-lethal murine systemic infection. Microbial Pathogenesis. 25(6). 349–352. 12 indexed citations

19.

Fulurija, Alma, Robert B. Ashman, & J. M. Papadimitriou. (1996). Early inflammatory responses toCandida albicansinfection in inbred and complement-deficient mice. FEMS Immunology & Medical Microbiology. 14(2-3). 83–94. 9 indexed citations

20.

Ashman, R. B., et al.. (1995). Cytokine mRNA in Brain Tissue from Mice that Show Strain-Dependent Differences in the Severity of Lesions Induced by Systemic Infection with Candida albicans Yeast. The Journal of Infectious Diseases. 172(3). 823–830. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact